ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko03030	DNA replication	17/117	38/7206	2.48067488013e-21
ko04110	Cell cycle	26/117	145/7206	1.26519257912e-20
ko04111	Cell cycle - yeast	14/117	90/7206	1.29301634659e-10
ko03410	Base excision repair	10/117	38/7206	2.78595180004e-10
ko04218	Cellular senescence	16/117	177/7206	2.06750997916e-08
ko03420	Nucleotide excision repair	8/117	46/7206	5.92222541829e-07
ko03430	Mismatch repair	6/117	22/7206	9.72242747017e-07
ko00240	Pyrimidine metabolism	11/117	110/7206	1.42104390141e-06
ko05222	Small cell lung cancer	10/117	89/7206	1.49665965348e-06
ko04113	Meiosis - yeast	8/117	70/7206	1.54916206085e-05
ko05219	Bladder cancer	6/117	48/7206	0.000113341055726
ko05212	Pancreatic cancer	7/117	83/7206	0.00037244375767
ko05215	Prostate cancer	8/117	111/7206	0.000416945935941
ko05161	Hepatitis B	10/117	173/7206	0.000476750867439
ko03440	Homologous recombination	5/117	41/7206	0.000486600556034
ko03040	Spliceosome	9/117	145/7206	0.000550333202135
ko05206	MicroRNAs in cancer	10/117	177/7206	0.000570978207224
ko05223	Non-small cell lung cancer	6/117	66/7206	0.000661939298674
ko04115	p53 signaling pathway	6/117	74/7206	0.0012149067868
ko03460	Fanconi anemia pathway	5/117	51/7206	0.00134074251756
ko05214	Glioma	6/117	79/7206	0.00170713558983
ko05218	Melanoma	6/117	85/7206	0.00248288036727
ko05220	Chronic myeloid leukemia	6/117	85/7206	0.00248288036727
ko01522	Endocrine resistance	7/117	124/7206	0.00391449916761
ko00230	Purine metabolism	9/117	194/7206	0.00416352591678
ko05200	Pathways in cancer	15/117	492/7206	0.0153042321183
ko05224	Breast cancer	7/117	174/7206	0.0228033596223
ko03450	Non-homologous end-joining	2/117	15/7206	0.023908674629
ko05166	HTLV-I infection	10/117	292/7206	0.0275364098105
ko05167	Kaposi's sarcoma-associated herpesvirus infection	7/117	191/7206	0.0354417828361
ko05162	Measles	5/117	120/7206	0.0452228802629